BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24023289)

  • 1. Effect of liposomal curcumin on red blood cells in vitro.
    Storka A; Vcelar B; Klickovic U; Gouya G; Weisshaar S; Aschauer S; Helson L; Wolzt M
    Anticancer Res; 2013 Sep; 33(9):3629-34. PubMed ID: 24023289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans.
    Storka A; Vcelar B; Klickovic U; Gouya G; Weisshaar S; Aschauer S; Bolger G; Helson L; Wolzt M
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):54-65. PubMed ID: 25500488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
    Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
    Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh PP; Burke TG; Ranjan D
    Int J Pharm; 2009 Jan; 366(1-2):133-9. PubMed ID: 18840516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
    Mach CM; Mathew L; Mosley SA; Kurzrock R; Smith JA
    Anticancer Res; 2009 Jun; 29(6):1895-9. PubMed ID: 19528445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis.
    Li L; Braiteh FS; Kurzrock R
    Cancer; 2005 Sep; 104(6):1322-31. PubMed ID: 16092118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of liposomes, trehalose, and hydroxyethyl starch for cryopreservation of human erythrocytes.
    Stoll C; Holovati JL; Acker JP; Wolkers WF
    Biotechnol Prog; 2012; 28(2):364-71. PubMed ID: 22275294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Liposomal Drug Formulations on the RBCs Shape, Transmembrane Potential, and Mechanical Properties.
    Cyboran-Mikołajczyk S; Sareło P; Pasławski R; Pasławska U; Przybyło M; Nowak K; Płóciennik M; Podbielska H; Kopaczyńska M; Wawrzyńska M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells.
    Raveendran R; Bhuvaneshwar G; Sharma CP
    J Biomater Appl; 2013 Mar; 27(7):811-27. PubMed ID: 22274881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effect of clinical propofol concentrations on red blood cell aggregation and deformability.
    Kim YH; Chung HG; Myung SA; Rha JH; Yang S; Nam MH; Shin SH; Lim CH
    Clin Hemorheol Microcirc; 2012; 51(4):287-92. PubMed ID: 22387482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of curcumin with lipid monolayers and liposomal bilayers.
    Karewicz A; Bielska D; Gzyl-Malcher B; Kepczynski M; Lach R; Nowakowska M
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):231-9. PubMed ID: 21778041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels.
    Jain SK; Rains J; Jones K
    Free Radic Biol Med; 2006 Jul; 41(1):92-6. PubMed ID: 16781457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells.
    Bolger GT; Licollari A; Bagshaw R; Tan A; Greil R; Vcelar B; Majeed M; Sordillo P
    Anticancer Res; 2019 Mar; 39(3):1161-1168. PubMed ID: 30842145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diethylene glycol butyl ether and butoxyethoxyacetic acid on rat and human erythrocytes.
    Udden MM
    Toxicol Lett; 2005 Mar; 156(1):95-101. PubMed ID: 15705490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
    Bolger GT; Licollari A; Tan A; Greil R; Vcelar B; Greil-Ressler S; Weiss L; Schönlieb C; Magnes T; Radl B; Majeed M; Sordillo PP
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):265-275. PubMed ID: 30430227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes composed of unsaturated lipids for membrane modification of human erythrocytes.
    Stoll C; Holovati JL; Acker JP; Wolkers WF
    Mol Membr Biol; 2011; 28(7-8):454-61. PubMed ID: 21954868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of preparation techniques on the properties of curcumin liposomes: characterization of size, release and cytotoxicity on a squamous oral carcinoma cell line.
    Gosangari SL; Watkin KL
    Pharm Dev Technol; 2012; 17(1):103-9. PubMed ID: 21091385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.